Hans Brandstetter

Title: Innovations by Hans Brandstetter

Introduction

Hans Brandstetter is a notable inventor based in Chelsea, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of muteins of avidin and streptavidin. With a total of 3 patents, his work has implications for diagnostic tests and molecular analysis.

Latest Patents

Brandstetter's latest patents include "Recombinant inactive core streptavidin mutants" and "Recombinant inactive avidin mutants." Both inventions focus on muteins of avidin and streptavidin that exhibit a reduced binding affinity for biotin. These muteins serve as interference elimination reagents in diagnostic tests, such as immunoassays and nucleic acid hybridization assays. Additionally, they can be utilized as systems capable of regeneration for binding biotin, which is essential for analyzing biotinylated molecules and examining receptor-ligand interactions.

Career Highlights

Hans Brandstetter is associated with Roche Diagnostics GmbH, where he continues to innovate in the field of diagnostics. His work has been instrumental in advancing methods for the determination of analytes, contributing to improved accuracy in diagnostic testing.

Collaborations

Brandstetter has collaborated with notable colleagues, including Rainer Müller and Richard Engh. Their combined expertise has furthered the development of innovative solutions in the field of biochemistry.

Conclusion

Hans Brandstetter's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to impact diagnostic testing and molecular analysis, showcasing the importance of innovation in science.